SCHEMBL845685

SCHEMBL845685

CCc1cccc(C(=O)N2CCC[C@H]2C(=O)Nc2ccc(/C=C/c3ccc(NC(=O)[C@@H]4CCCN4C(=O)c4cc(CC)ccn4)cc3)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53BP1 Q12888 2/20 0.46
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
ALDH1A1 P00352 2/20 0.42
RHOC P08134 1/20 0.41
RHOA P61586 1/20 0.41
ROCK2 O75116 1/20 0.41
PABPC1 P11940 1/20 0.41
GAA P10253 1/20 0.40
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
BRAF P15056 1/20 0.40
CFTR P13569 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845570 0.93 TP53BP1 (0.45) TP53BP1KDM4ELMNAALDH1A1RHOC
SCHEMBL13272513 0.81 CFTR (0.38) TP53BP1KDM4ELMNAALDH1A1RHOC
SCHEMBL13272494 0.81 TP53BP1 (0.38) TP53BP1KDM4ELMNAALDH1A1RHOC
SCHEMBL845048 0.78 DGAT1 (0.50) KDM4ELMNAALDH1A1RHOCRHOA
SCHEMBL845935 0.77 PABPC1 (0.44) TP53BP1KDM4ELMNAALDH1A1PABPC1
SCHEMBL845157 0.77 ALDH1A1 (0.57) LMNAALDH1A1ROCK2CFTRTDP1
SCHEMBL845300 0.77 CYP2C9 (0.54) ALDH1A1RHOCRHOAROCK2PABPC1
SCHEMBL845333 0.76 PABPC1 (0.48) KDM4ELMNAALDH1A1RHOCRHOA
SCHEMBL845405 0.76 TRPV1 (0.46) KDM4ERHOCRHOAPOLBMAPT
SCHEMBL845297 0.75 RHOC (0.48) LMNAALDH1A1RHOCRHOAROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed